Published in Lung on January 01, 1978
The role of disulphide bonds in human intestinal mucin. Biochem J (1979) 1.05
Monoclonal antibodies as probes for unique antigens in secretory cells of mixed exocrine organs. Proc Natl Acad Sci U S A (1984) 0.83
Mucin Binding Reduces Colistin Antimicrobial Activity. Antimicrob Agents Chemother (2015) 0.78
Glycoconjugate secretion in human airways in vitro: effects of epithelium removal. Mediators Inflamm (1998) 0.77
Aspergillosis and the role of mucins in cystic fibrosis. Pediatr Pulmonol (2016) 0.76
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J (2001) 3.04
Abnormal distribution of cystic fibrosis delta F508 allele in adults with chronic bronchial hypersecretion. Lancet (1990) 2.23
[Vaginal vault suspension by posterior transobturator sling]. Gynecol Obstet Fertil (2007) 2.04
Molecular cloning and chromosomal localization of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. Biochem Biophys Res Commun (1991) 2.01
Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature. Lung Cancer (2005) 1.92
The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature. Br J Cancer (2001) 1.82
IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol (2000) 1.75
Axonemal dynein intermediate-chain gene (DNAI1) mutations result in situs inversus and primary ciliary dyskinesia (Kartagener syndrome). Am J Hum Genet (2001) 1.75
Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin. Biochem J (1999) 1.67
Pseudomonas aeruginosa recognizes carbohydrate chains containing type 1 (Gal beta 1-3GlcNAc) or type 2 (Gal beta 1-4GlcNAc) disaccharide units. Infect Immun (1991) 1.62
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis. Eur Respir J (2002) 1.57
Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics (1997) 1.55
Complex structure of human bronchial mucus glycoprotein. Eur J Biochem (1984) 1.54
High-dose and low-dose systemic corticosteroids are equally efficient in acute severe asthma. Eur Respir J (1995) 1.48
Human mucin genes assigned to 11p15.5: identification and organization of a cluster of genes. Genomics (1996) 1.48
[Study of carboxylic and sulfated glycoproteins in human bronchial mucus]. Clin Chim Acta (1967) 1.45
Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer (2001) 1.44
Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med (1999) 1.43
Characterization of the human mucin gene MUC5AC: a consensus cysteine-rich domain for 11p15 mucin genes? Biochem J (1995) 1.42
Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis. Lung Cancer (2002) 1.40
Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains resulting in a super-repeat. Structural evidence for a 11p15.5 gene family. J Biol Chem (1997) 1.40
Influence of deep hypothermia on the tolerance of the isolated cardiomyocyte to ischemia-reperfusion. J Mol Cell Cardiol (2001) 1.39
Effects of tumour mass and circulating antigen on the biodistribution of 111In-labelled F(ab')2 fragments of human prostatic acid phosphatase monoclonal antibody in nude mice bearing PC-82 human prostatic tumour xenografts. Eur J Nucl Med (1991) 1.38
In vivo release of mitotic silencing of ribosomal gene transcription does not give rise to precursor ribosomal RNA processing. J Cell Biol (2000) 1.38
A flexible germanate structure containing 24-ring channels and with very low framework density. J Am Chem Soc (2001) 1.35
Abnormal distribution of CF delta F508 allele in azoospermic men with congenital aplasia of epididymis and vas deferens. Lancet (1990) 1.33
The mitotically phosphorylated form of the transcription termination factor TTF-1 is associated with the repressed rDNA transcription machinery. J Cell Sci (1999) 1.32
Peripheral neuropathy and vibration syndrome. A clinical and neurophysiological study of 103 patients. Int Arch Occup Environ Health (1983) 1.30
Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. J Allergy Clin Immunol (2001) 1.30
Genomic organization of the 3' region of the human mucin gene MUC5B. J Biol Chem (1997) 1.28
Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J Biol Chem (2001) 1.28
A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. Lung Cancer (2000) 1.27
Degenerate 87-base-pair tandem repeats create hydrophilic/hydrophobic alternating domains in human mucin peptides mapped to 11p15. Biochem J (1993) 1.27
Massive hemoptysis of pulmonary arterial origin: diagnosis and treatment. AJR Am J Roentgenol (1984) 1.26
[Study of the fibrillar structures of human bronchial secretion]. Clin Chim Acta (1967) 1.25
Evidence for different human tracheobronchial mucin peptides deduced from nucleotide cDNA sequences. Am J Respir Cell Mol Biol (1991) 1.24
Reactive arthritis after hepatitis B vaccination. J Rheumatol (1990) 1.20
Evolution of the large secreted gel-forming mucins. Mol Biol Evol (2000) 1.20
Genomic organization of the human mucin gene MUC5B. cDNA and genomic sequences upstream of the large central exon. J Biol Chem (1998) 1.18
Peptides of human bronchial mucus glycoproteins. Size determination by electron microscopy and by biosynthetic experiments. Biochem J (1987) 1.18
Human mucin gene MUC4: organization of its 5'-region and polymorphism of its central tandem repeat array. Biochem J (1998) 1.18
The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from chronic bronchitis is related to the severity of airway infection. Glycobiology (1999) 1.17
Chemical and physical properties of human bronchial mucus glycoproteins. Biochimie (1979) 1.16
Human mucin genes MUC2, MUC3, MUC4, MUC5AC, MUC5B, and MUC6 express stable and extremely large mRNAs and exhibit a variable length polymorphism. An improved method to analyze large mRNAs. J Biol Chem (1998) 1.16
Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus. Int J Cancer (2000) 1.14
Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. Gastroenterology (1996) 1.14
Differences in adhesion of Pseudomonas aeruginosa to mucin glycopeptides from sputa of patients with cystic fibrosis and chronic bronchitis. Infect Immun (1989) 1.13
Chemical and immunological characterization of specific glycoproteins from Trypanosoma equiperdum variants. FEBS Lett (1977) 1.13
Stimulation of the secretion of latent cysteine proteinase activity by tumor necrosis factor alpha and interleukin-1. Arthritis Rheum (1993) 1.11
Qualitative study of fecal alpha 1-proteinase inhibitor in normal subjects and patients with Crohn's disease. Clin Chem (1988) 1.11
Structure of sialyl-oligosaccharides isolated from bronchial mucus glycoproteins of patients (blood group O) suffering from cystic fibrosis. Eur J Biochem (1987) 1.10
Characterization of a UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase that displays glycopeptide N-acetylgalactosaminyltransferase activity. J Biol Chem (1999) 1.10
The complexity of mucins. Biochimie (1988) 1.10
Involvement of glycosylation in the intracellular trafficking of glycoproteins in polarized epithelial cells. Biochimie (2003) 1.09
Cloning and characterization of a ninth member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family, ppGaNTase-T9. J Biol Chem (2001) 1.09
Trypanosoma brucei: the extent of conversion in antigen genes may be related to the DNA coding specificity. Cell (1985) 1.09
Metabolic interaction between m-xylene and ethanol. Arch Toxicol (1982) 1.08
The AgNOR proteins: qualitative and quantitative changes during the cell cycle. Micron (2000) 1.07
Cystic fibrosis and congenital absence of the vas deferens. N Engl J Med (1991) 1.07
The binding of anti-pseudomonal antibiotics to macromolecules from cystic fibrosis sputum. J Antimicrob Chemother (1988) 1.06
Studies on contact sensitivity to chromium in the guinea pig. The role of valence in the formation of the antigenic determinant. J Invest Dermatol (1983) 1.06
Polymorphism of human mucin genes in chest disease: possible significance of MUC2. Am J Respir Cell Mol Biol (2000) 1.06
[VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis]. Rev Mal Respir (2002) 1.05
Amount of the two major Ag-NOR proteins, nucleolin, and protein B23 is cell-cycle dependent. Cytometry (1997) 1.05
Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa. Am J Respir Cell Mol Biol (1993) 1.05
Alternative splicing generates a family of putative secreted and membrane-associated MUC4 mucins. Eur J Biochem (2000) 1.05
Primary-structure determination of fourteen neutral oligosaccharides derived from bronchial-mucus glycoproteins of patients suffering from cystic fibrosis, employing 500-MHz 1H-NMR spectroscopy. Eur J Biochem (1982) 1.04
Recognition of Lewis x derivatives present on mucins by flagellar components of Pseudomonas aeruginosa. Infect Immun (2001) 1.04
Evidence for the in vivo degradation of human respiratory mucins during Pseudomonas aeruginosa infection. Biochim Biophys Acta (1989) 1.03